Rapid Micro Biosystems, Inc. (RPID) stock
RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3056% below fair value
$0.67−0.08 (-10.19%)
Close on Nov 12, 2026Market cap $33.66MP/E –Yield –
Rapid Micro Biosystems ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Rapid Micro Biosystems's ebitda for the twelve months ending Jun 30, 2026 was -$46.78M. For fiscal 2025 it was -$44.14M. The highest annual figure on record is -$29.03M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$44.14M | – |
| FY2024 | Dec 31, 2024 | -$46.56M | – |
| FY2023 | Dec 31, 2023 | -$53.46M | – |
| FY2022 | Dec 31, 2022 | -$60.38M | – |
| FY2021 | Dec 31, 2021 | -$45.70M | – |
| FY2020 | Dec 31, 2020 | -$29.03M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.15M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.42M | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$11.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.81M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.36M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.55M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.47M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.39M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.67M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$14.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.40M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.15M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.47M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.44M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.11M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.72M | – |
| Q2 FY2021 | Jun 30, 2021 | -$10.56M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.35M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.40M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.28M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.61M | – |
See a number that looks wrong?